Molecular Bioelectrostatics & Drug Delivery Laboratory
The Bajpayee Lab works at the intersection of biomaterials design, nanomedicine and translational research. We utilize the body’s internal electric fields to design electrically charged biomaterials using proteins, peptides and cellular materials like exosomes, for targeting difficult to reach tissues for applications in drug delivery and diagnostic imaging.
Negatively charged tissues such as cartilage, meniscus, intervertebral disc, eye, and mucosal membrane, that also tend to be dense and avascular, are ubiquitous in the human body but remain outstanding challenges for targeted drug delivery. Their degeneration is associated with several common diseases that remain untreatable due to a lack of delivery systems that can enable drugs to penetrate the negatively charged matrix and reach their cellular targets. The high negative fixed charge density, however, can be converted from being a challenge to an opportunity by engineering therapeutics at the molecular level to add optimally positively charged domains such that electrostatic interactions can enhance their transport, uptake and retention rather than hindering them. Our lab engineers targeted bioelectrical therapeutics for treatment of diseases affecting such intrinsically charged tissues. We strive to combine basic science with translational research to develop biomedical technologies for unmet clinical needs.
Follow us on Twitter @bajpayeelab | @AmbikaBajpayee

We are supported by

Our Lab News
Helna Earns OARSI 2026 Early Career Investigator Travel Support Award
Congratulations to Helna Mary on receiving the OARSI 2026 ECI Travel Support Award! Well-deserved recognition for her work and a great opportunity to connect with the OA research community in West Palm Beach. https://congress.oarsi.org/awards
ORS 2026 Recap!
We had a great time at ORS 2026 presenting our work and getting to see the latest developments in the orthopedic field. It was a great time full of science and catching up with old friends.
Check out our work at the ORS 2026 Annual Meeting in Charlotte, NC!
Helna, Bill, Andrew, and Hengli will share exciting work on charge-based drug and gene delivery for osteoarthritis treatment. Please stop by our talk and posters! We're looking forward to it!





